All lobbying filings

Washington Advocacy Group

Washington Advocacy Group filed a Q4 report for Amgen Inc. on January 19, 2026, reporting $20,000 in lobbying income.

Lobbying for Amgen Inc. · Biotechnology

As filed: WASHINGTON ADVOCACY GROUP for AMGEN INC.

All filings by Washington Advocacy Group · Everything Amgen Inc. has reported

Filing · LD-2 quarterly report Q4 report

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Jan 19, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 1

SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Monitor healthcare regulations and statutes and educate members of Congress on issues with regard to client's interests

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.